Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study

Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study

Abstract Background Pirfenidone slows down disease progression in idiopathic pulmonary fibrosis (IPF). Recent studies suggest a treatment effect in progressive pulmonary fibrosis other than IPF. However, the safety and effectiveness of pirfenidone in asbestosis patients remain unclear. In this study...

Full description

Bibliographic Details
Main Authors: Jelle R. Miedema, Catharina C. Moor, Marcel Veltkamp, Sara Baart, Natascha S. L. Lie, Jan C. Grutters, Marlies S. Wijsenbeek, Rémy L. M. Mostard
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Respiratory Research
Subjects:
Asbestosis
Pirfenidone
Anti-fibrotic treatment
Safety
Efficacy
Home monitoring
Online Access:https://doi.org/10.1186/s12931-022-02061-2

Internet

https://doi.org/10.1186/s12931-022-02061-2

Similar Items